Mark Nuttall

VP, Quality Assurance

Mark has been working in the pharmaceutical industry for more than 25 years with a primary focus on new drug development and commercialization.  He has extensive experience in analytical and formulation development, quality assurance, and compilation of regulatory documentation. Over his career, Mark has been heavily involved in over 35 successful new product launches, both domestic and global, which includes 8 NDAs.

Prior to joining Renibus, Mark was the Vice President of Quality at AstraZeneca (formerly ZS Pharma) where he was a key member of the Lokelma development team.  He was responsible for establishing a Quality System for 2 US facilities, and the design, buildout, and expansion of the Quality functional areas at each facility.

Prior to ZS Pharma, Mark held multiple roles at Reckitt Benckiser North America (formerly Adams Respiratory Therapeutics) with his most recent role being one of two key leaders tasked with all new product development.  During his time in this role, the Mucinex product line expanded from the 6 core products to more than 20 that were successfully launched in multiple countries.

Mark received his Bachelor of Science in Biology from the University of Texas at Arlington in 1992 and is listed as an inventor on 2 international patents.

Back to Home